SELLAS Life Sciences Group Inc (NASDAQ: SLS) Is Under Pressure Due To Weak Fundamental Momentum.

NOVA

In the last trading session, 3.89 million SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares changed hands as the company’s beta touched 2.23. With the company’s per share price at $1.75 changed hands at $0.12 or 7.36% during last session, the market valuation stood at $174.61M. SLS’s last price was a discount, traded about -5.71% off its 52-week high of $1.85. The share price had its 52-week low at $0.77, which suggests the last value was 56.0% up since then.

Analysts gave the SELLAS Life Sciences Group Inc (SLS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SLS as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.

SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information

Instantly SLS was in green as seen at the end of in last trading. With action 13.64%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 68.27%, with the 5-day performance at 13.64% in the green. However, in the 30-day time frame, SELLAS Life Sciences Group Inc (NASDAQ:SLS) is 33.59% up.

The consensus price target for the stock as assigned by Wall Street analysts is 2.8, meaning bulls need an upside of 37.5% from its current market value. According to analyst projections, SLS’s forecast low is 2.4 with 3.2 as the target high. To hit the forecast high, the stock’s price needs a -82.86% plunge from its current level, while the stock would need to soar -37.14% for it to hit the projected low.

SELLAS Life Sciences Group Inc (SLS) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 45.94%. The 2025 estimates are for SELLAS Life Sciences Group Inc earnings to increase by 33.00%, but the outlook for the next 5-year period is at 50.68% per year.

SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s Major holders

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds the second largest percentage of outstanding shares, with 3.6594% or 1.64 million shares worth $1.95 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund. With 1.69 shares estimated at $2.96 million under it, the former controlled 1.69% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.50% of the shares, roughly 501.97 shares worth around $0.88 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.